^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Mepact (mifamurtide)

i
Company:
Medison, Takeda
Drug class:
Macrophage stimulant, Monocyte stimulant
Phase N/A
Istituto Ortopedico Rizzoli
Recruiting
Last update posted :
03/22/2024
Initiation :
12/12/2018
Primary completion :
06/30/2024
Completion :
06/30/2024
PD-L1 • CD68
|
Mepact (mifamurtide)